NTM INFEcT
Funded by the Center for Disease Control (CDC), NTM INFEcT is a registry of persons infected with nontuberculous mycobacteria (NTM) after exposure to hearter cooler units during cardiothoracic...
NILO-PD
Funded by the Michael J. Fox Foundation, NILO-PD is a Phase II clinical trial to evaluate the safety and tolerability of nilotinib in Parkinson's disease. The CTSDMC is the statistical core for this...
Fox Insight
Funded by the Michael J. Fox Foundation, Fox Insight is an online clinical study collecting a core set of longitudinal data from participants via web portal. The primary objective of this study is to...
Systemic Synuclein Sampling Study (S4)
Funded by the Michael J. Fox Foundation, the Systemic Synuclein Sampling Study (S4) is an observational clinical study to better understand the progression of Parkinson's Disease by identifying the...
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention (MedFocus) is a multi-center, cluster-randomized study using a centralized cardiovascular risk service (CVSR) in...
Clinical Trials Methodology Course
The Clinical Trials Methodology Course (CTMC) is a course for junior researchers in neurology-focused clinical trials. Currently funded via R25 NS088248, the CTMC is managed by Dr. William Meurer at...
NeuroNEXT
The Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) was created to conduct studies of treatments for neurological diseases through partnerships with academia, private foundations,...
CHAMP
The Childhood and Adolescent Migraine Prevention Study (CHAMP) was conducted jointly with clinical investigators from Cincinnati Children's Hospital. The study tested two treatments for children and...
LRRK2 Cohort Consortium
The LRRK2 Cohort Consortium, funded by the Michael J. Fox Foundation, brought research groups together to speed efforts to move LRRK2 toward therapeutic relevance for patients. The CTSDMC served as...